Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Alzheimer’s disease now impacts over seven million individuals across the United States, highlighting a pressing public health issue. Additionally, a significant majority of Americans—nearly four in five—express a desire to learn about their Alzheimer’s risk before any symptoms appear. This statistic emerges from the Alzheimer’s Association’s annual report, which is titled “Alzheimer’s Disease Facts and Figures.”
Dr. Elizabeth Edgerly, a senior director for Community Programs and Services at the Alzheimer’s Association, recently shared insights into the changing perception surrounding early detection. In a conversation with Fox News Digital, she remarked on how advancements in technology have initiated a shift. She indicated that more people are now embracing the possibility of early testing, contrasting earlier sentiments where many felt apprehensive about finding out. This change plays a crucial role in reducing the stigma associated with Alzheimer’s.
In the past, pre-symptomatic testing for Alzheimer’s often relied on expensive and invasive procedures, such as PET scans or spinal taps. These methods could deter many individuals from seeking out diagnosis due to cost and complexity. Dr. Edgerly pointed out that determining the urgency of symptoms remains a challenge for families. People frequently grapple with whether changes they observe are part of normal aging or indications of something more serious.
Moreover, diagnosis could take an extended period. Dr. Edgerly explained that patients often endure a protracted process, sometimes ranging from months to years, before receiving a definitive diagnosis.
The introduction of new blood tests that can predict the likelihood of developing Alzheimer’s presents a significant breakthrough. These tests offer a more straightforward and less intimidating option for individuals concerned about Alzheimer’s. Dr. Edgerly emphasized that accessibility is a key advantage, making the testing process much more manageable. Now, individuals can secure answers without the burden of invasive procedures.
As the public’s understanding and demand for testing grow, so does the concern surrounding costs related to Alzheimer’s care. The Alzheimer’s Association projects the national cost for caring for patients with Alzheimer’s and other dementias will reach a staggering $384 billion by the year 2025, an increase of $24 billion since the previous year.
Family caregivers also play a crucial role in this equation. Nearly 12 million friends and family members dedicate approximately 19.2 billion hours annually to provide unpaid care, which stands to be valued at an astounding $413 billion. Dr. Edgerly commented on the emotional weight of caregiving, noting, “Anyone who has cared for someone or has close friends who have been affected… it’s hard to not want to change that.” Her personal experience of her mother suffering from a form of dementia adds heartfelt resonance to her observations.
Recent surveys indicate a shift in public attitude towards taking medications that may help slow the progression of Alzheimer’s. Three out of five respondents expressed willingness to accept moderate to high risks associated with such treatments. Despite the ongoing need for comprehensive research into the disease’s progression, Dr. Edgerly suggests that individuals can adopt lifestyle changes that may influence their risk factor.
Dietary choices play an essential role. Dr. Edgerly recommends a diet rich in fruits and vegetables, often exemplified by the Mediterranean diet, alongside regular exercise. Moreover, managing health conditions, such as high blood pressure, appears to yield positive outcomes.
With over 140 potential treatment options currently under investigation, Dr. Edgerly observes a sense of optimism brewing among Americans regarding Alzheimer’s. This sentiment prevails despite the increasing risk associated with an aging population. She noted a significant rise in the recognition of Alzheimer’s, stating, “For a long time—and still—many people don’t get diagnosed. But those numbers are changing.”
Dr. Edgerly concluded with a vision for the future, likening the shift in Alzheimer’s understanding to the progress seen with cancer awareness. She hopes for a landscape where open discussions, support, and resources become commonplace, fostering a culture of survivorship.
The journey with Alzheimer’s can be daunting, yet the growing openness and advancements in detection embody hope for millions affected by this condition.